Monday, Jan 12, 2026 · SEC filings

What the smart money revealed on Jan 12

Real insider buys30insiders · $65.6M
Real insider sales34insiders · $36M
Fund 13Fs filed—not loaded for this day
Activist 13Ds filed—not loaded for this day

433 insider filings came in. We hid 50 planned (10b5-1) sellers and 299 people whose filings were routine, like grants and tax withholding.

trending_up

Aktis Oncology (AKTS) Director Oleg Nodelman bought $40M

2.22M shares on the open market. Not a grant or an option exercise. Their past buys: 3 of 3 checked quarters beat the typical stock 6 months later.

Real buy Form 4 Past buys: 3 of 3 beat Traded Jan 12
$40M
trending_up

Aktis Oncology (AKTS) Director Helen Kim bought $15M

835,000 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Jan 12
$15M
trending_up

Alumis (ALMS) Director James Tananbaum bought $7M

411,764 shares on the open market. Not a grant or an option exercise. Their past buys: 1 of 3 checked quarters beat the typical stock 6 months later.

Real buy Form 4 Past buys: 1 of 3 beat Traded Jan 8
$7M
trending_up

Agree Realty (ADC) Executive Chairman of Board Richard Agree bought $1.7M

24,000 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Jan 9
$1.7M
trending_down

Diversified Energy (DEC) Director Randall Wade sold $27.9M

Not marked as a planned 10b5-1 sale. Sold 22% of the shares they held directly. Still holds 7.5M shares.

Real sale Form 4 Traded Jan 9
$27.9M
trending_down

AAR (AIR) Senior Vice President-CCO Christopher Jessup sold $2.29M

Not marked as a planned 10b5-1 sale. Sold 26% of the shares they held directly. Still holds 65,769 shares.

Real sale Form 4 Sold 26% of stake Traded Jan 9
$2.29M
trending_down

Netskope (NTSK) Chief Revenue Offucer Raphael Bousquet sold $171K

Not marked as a planned 10b5-1 sale. Sold every share held directly.

Real sale Form 4 Sold 100% of stake Traded Jan 8–12
$171K
Show 26 more real buys
TCGSX TCG Strategic Income Fund · Director Leonard Tannenbaum · Traded Jan 9
$950K
MSTR Strategy · Director Carl Rickertsen · Traded Jan 12
$779K
PDX Pimco Dynamic Income Strategy Fund · Director Alan Rappaport · Traded Jan 8
$37.9K
LAKE Lakeland Industries · COO An Hui · Traded Jan 9
$17.9K
NXG NXG NextGen Infrastructure Income Fund · CFO & Treasurer Blake Nelson · Traded Jan 8
$16.5K
MAIA MAIA Biotechnology · Director Stan Smith · Traded Sep 19
$9.96K
GRX Gabelli Healthcare & WellnessRx Trust · Director Mario Gabelli · Traded Jan 8
$9.48K
BUKS Butler National · Director Michael Loh · Traded Jan 9
$5.92K
BUKS Butler National · CEO and President Christopher Reedy · Traded Jan 12
$5.68K
CZNC Citizens & Northern · Director Frank Pellegrino · Traded Jan 9
$4.08K
RCG RENN Fund · President/Co-Portfolio Manager Murray Stahl · Traded Jan 9
$2.95K
Dynamic Alternatives Fund · President Jeffrey Wilkins · Traded Jun 2
$2.54K
INTZ Intrusion · CFO Kimberly Pinson · Traded Dec 31
$2.45K
LUCY Innovative Eyewear · CEO Harrison Gross · Traded Jan 8
$2.4K
INTZ Intrusion · CEO Anthony Scott · Traded Dec 31
$2.13K
LUCY Innovative Eyewear · Chief AI & Growth Officer Konrad Dabrowski · Traded Jan 8
$2.05K
VCX Fundrise Growth Tech Fund · Secretary and CCO Bjorn Hall · Traded Jan 9
$791
Fundrise Real Estate Interval Fund · President Benjamin Miller · Traded Jan 9
$695
Fundrise Real Estate Interval Fund · Treasurer Alison Staloch · Traded Jan 9
$618
Fundrise Income Real Estate Fund · Director Gayle Starr · Traded Jan 9
$560
VCX Fundrise Growth Tech Fund · Director Glenn Osaka · Traded Jan 9
$397
CZNC Citizens & Northern · Director Katherine Shattuck · Traded Jan 9
$387
Fundrise Income Real Estate Fund · Director Mark Monte · Traded Jan 9
$383
Fundrise Real Estate Interval Fund · Director Gayle Starr · Traded Jan 9
$151
Fundrise Real Estate Interval Fund · Director Mark Monte · Traded Jan 9
$122
Fundrise Income Real Estate Fund · Treasurer Alison Staloch · Traded Jan 9
$59
Show 31 more real sales
COST Costco Wholesale · Sr. Executive Vice President Russell Miller · Traded Jan 9
$1.37M
FDS FactSet Research Systems · Director Laurie Siegel · Traded Jan 8
$762K
ZYME Zymeworks · Chair & CEO Kenneth Galbraith · Traded Jan 12
$690K
ACLX Arcellx · Chief Medical Officer Christopher Heery · Traded Jan 12
$393K
AZZ Azz · Chief Legal Officer Tara Mackey · Traded Jan 8–9
$306K
ZYME Zymeworks · Chief Scientific Officer Paul Moore · Traded Jan 12
$217K
ZYME Zymeworks · EVP & Chief Medical Officer Jeffrey Smith · Traded Jan 12
$211K
CXW CoreCivic · Director John Prann · Traded May 19
$180K
NXXT Nextnrg · Director Jack Leibler · Traded Nov 21
$154K
PHR Phreesia · CEO Chaim Indig · Traded Jan 8
$144K
PHR Phreesia · CFO Balaji Gandhi · Traded Jan 8
$136K
PHR Phreesia · General Counsel & Secretary Allison Hoffman · Traded Jan 8
$112K
PHR Phreesia · President Evan Roberts · Traded Jan 8
$107K
PHR Phreesia · President David Linetsky · Traded Jan 8
$104K
ESTC Elastic N.V. · GVP & CAO Jane Bone · Traded Jan 9
$95.3K
ABOS Acumen Pharmaceuticals · Chief Legal Officer & Corp Sec Derek Meisner · Traded Jan 8–12
$90.9K
MOVE Movano · CFO Jeremy Cogan · Traded Jan 5–6
$79.7K
PASG Passage BIO · President and CEO William Chou · Traded Jan 8
$75.2K
CPB Campbell's · EVP Anthony Sanzio · Traded Jan 9
$71.6K
MOVE Movano · CTO Michael Leabman · Traded Jan 7–9
$55.9K
ABOS Acumen Pharmaceuticals · CEO Daniel OConnell · Traded Jan 8–12
$46.9K
PHR Phreesia · SVP Amy VanDuyn · Traded Jan 8
$44.3K
PASG Passage BIO · CFO Kathleen Borthwick · Traded Jan 8
$38K
QUBT Quantum Computing · COO Milan Begliarbekov · Traded Jan 7
$33.9K
IDT Idt · CFO Marcelo Fischer · Traded Jan 8
$33.5K
MOV Movado Group · SVP Michelle Kennedy · Traded Dec 9
$26.9K
EXFY Expensify · Director Divo Alvarez · Traded Dec 30–31
$13.5K
ABOS Acumen Pharmaceuticals · CFO & Chief Business Officer Matt Zuga · Traded Jan 8
$12.5K
FATE Fate Therapeutics · Officer Cindy Tahl · Traded Jan 9
$11.2K
ABOS Acumen Pharmaceuticals · COO Russell Barton · Traded Jan 8
$6.57K
FATE Fate Therapeutics · President and CEO Bahram Valamehr · Traded Jan 9
$5.55K

13F season

Holdings as of Dec 31, 2025 are due Feb 17

320 funds have filed so far. 81 filed for the quarter before.

Biggest real insider buys this week

Open-market buys by officers and directors, filed in the 7 days up to Jan 12.

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate. Daily closing prices come from post-no-preference/stocks on DoltHub, a community-run database shared under CC BY-SA 4.0; the prices we show stay under that license. They are each day's close, not live or official exchange prices.

This is data, not investment advice. About StockToast · Your watchlist